Abstract
Mitochondrial permeability transition (mPT) is a phenomenon that abruptly causes the flux of low molecular weight solutes (molecular weight up to 1,500) across the generally impermeable inner mitochondrial membrane. The mPT is mediated by the so-called mitochondrial permeability transition pore (mPTP), a supramolecular entity assembled at the interface of the inner and outer mitochondrial membranes. In contrast to mitochondrial outer membrane permeabilization, which mostly activates apoptosis, mPT can trigger different cellular responses, from the physiological regulation of mitophagy to the activation of apoptosis or necrosis. Although there are several molecular candidates for the mPTP, its molecular nature remains contentious. This lack of molecular data was a significant setback that prevented mechanistic insight into the mPTP, pharmacological targeting and the generation of informative animal models. In recent years, experimental evidence has highlighted mitochondrial F1Fo ATP synthase as a participant in mPTP formation, although a molecular model for its transition to the mPTP is still lacking. Recently, the resolution of the F1Fo ATP synthase structure by cryogenic electron microscopy led to a model for mPTP gating. The elusive molecular nature of the mPTP is now being clarified, marking a turning point for understanding mitochondrial biology and its pathophysiological ramifications. This Review provides an up-to-date reference for the understanding of the mammalian mPTP and its cellular functions. We review current insights into the molecular mechanisms of mPT and validated observations — from studies in vivo or in artificial membranes — on mPTP activity and functions. We end with a discussion of the contribution of the mPTP to human disease. Throughout the Review, we highlight the multiple unanswered questions and, when applicable, we also provide alternative interpretations of the recent discoveries.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486–541 (2018).
Nakamura-Ishizu, A., Ito, K. & Suda, T. Hematopoietic stem cell metabolism during development and aging. Dev. Cell 54, 239–255 (2020).
Giorgi, C., Marchi, S. & Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 713–730 (2018).
Zhang, F., Zhang, L., Qi, Y. & Xu, H. Mitochondrial cAMP signaling. Cell Mol. Life Sci. 73, 4577–4590 (2016).
Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363–383 (2020).
Hansen, K. G. & Herrmann, J. M. Transport of proteins into mitochondria. Protein J. 38, 330–342 (2019).
Giacomello, M., Pyakurel, A., Glytsou, C. & Scorrano, L. The cell biology of mitochondrial membrane dynamics. Nat. Rev. Mol. Cell Biol. 21, 204–224 (2020).
Rosencrans, W. M., Rajendran, M., Bezrukov, S. M. & Rostovtseva, T. K. VDAC regulation of mitochondrial calcium flux: from channel biophysics to disease. Cell Calcium 94, 102356 (2021).
Haworth, R. A. & Hunter, D. R. The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch. Biochem. Biophys. 195, 460–467 (1979).
Hunter, D. R. & Haworth, R. A. The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch. Biochem. Biophys. 195, 468–477 (1979).
Hunter, D. R. & Haworth, R. A. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195, 453–459 (1979). This work, together with workfrom Haworth and Hunter (1979) and Hunter and Haworth (1979), formallydefines the properties of mPT from isolated mitochondria.
Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).
Giorgio, V. et al. Cyclophilin D in mitochondrial pathophysiology. Biochim. Biophys. Acta 1797, 1113–1118 (2010).
Bonora, M. et al. Physiopathology of the permeability transition pore: molecular mechanisms in human pathology. Biomolecules 10, 998 (2020).
Spikes, T. E., Montgomery, M. G. & Walker, J. E. Structure of the dimeric ATP synthase from bovine mitochondria. Proc. Natl Acad. Sci. USA 117, 23519–23526 (2020).
Alavian, K. N. et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc. Natl Acad. Sci. USA 111, 10580–10585 (2014).
Giorgio, V. et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl Acad. Sci. USA 110, 5887–5892 (2013). Together with Alavian et al. (2014), this study is the firstto demonstrate that purified ATP synthase can generate mPTP-like currents inartificial membrane systems.
Urbani, A. et al. Purified F-ATP synthase forms a Ca2+-dependent high-conductance channel matching the mitochondrial permeability transition pore. Nat. Commun. 10, 4341 (2019).
Mnatsakanyan, N. et al. A mitochondrial megachannel resides in monomeric F1FO ATP synthase. Nat. Commun. 10, 5823 (2019).
Bonora, M. et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12, 674–683 (2013). This work proposes for the first time the involvement of ATP synthase in mPTP composition.
Bonora, M. et al. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. EMBO Rep. 18, 1077–1089 (2017).
Galber, C. et al. The f subunit of human ATP synthase is essential for normal mitochondrial morphology and permeability transition. Cell Rep. 35, 109111 (2021).
Carraro, M. et al. Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J. Biol. Chem. 289, 15980–15985 (2014).
Carraro, M. et al. The unique cysteine of F-ATP synthase OSCP subunit participates in modulation of the permeability transition pore. Cell Rep. 32, 108095 (2020).
Giorgio, V. et al. Ca2+ binding to F-ATP synthase beta subunit triggers the mitochondrial permeability transition. EMBO Rep. 18, 1065–1076 (2017).
Antoniel, M. et al. The unique histidine in OSCP subunit of F-ATP synthase mediates inhibition of the permeability transition pore by acidic pH. EMBO Rep. 19, 257–268 (2018).
Guo, L. et al. Arginine 107 of yeast ATP synthase subunit g mediates sensitivity of the mitochondrial permeability transition to phenylglyoxal. J. Biol. Chem. 293, 14632–14645 (2018).
Ichas, F. & Mazat, J. P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta 1366, 33–50 (1998).
Szabo, I. & Zoratti, M. The mitochondrial megachannel is the permeability transition pore. J. Bioenerg. Biomembr. 24, 111–117 (1992). This study describes for the first time the electrophysiological properties of the mPTP.
Savage, M. K. & Reed, D. J. Release of mitochondrial glutathione and calcium by a cyclosporin A-sensitive mechanism occurs without large amplitude swelling. Arch. Biochem. Biophys. 315, 142–152 (1994).
Neginskaya, M. A. et al. ATP synthase c-subunit-deficient mitochondria have a small cyclosporine a-sensitive channel, but lack the permeability transition pore. Cell Rep. 26, 11–17 e12 (2019). This work describes an mPTP-like low-conductance current attributable to ANT in cells deprived of the c-ring of ATP synthase.
Szabo, I. & Zoratti, M. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett. 330, 201–205 (1993).
Boyman, L. et al. Dynamics of the mitochondrial permeability transition pore: transient and permanent opening events. Arch. Biochem. Biophys. 666, 31–39 (2019).
Petronilli, V. et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76, 725–734 (1999).
Elrod, J. W. et al. Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120, 3680–3687 (2010). This study describes cellular metabolism in Ppif−/− mouse models, providing the first evidence for a role of the mPTP in the physiological regulation of metabolism.
Giorgio, V., Guo, L., Bassot, C., Petronilli, V. & Bernardi, P. Calcium and regulation of the mitochondrial permeability transition. Cell Calcium 70, 56–63 (2018).
Karch, J. et al. Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. Sci. Adv. 5, eaaw4597 (2019). The complete knockdown of all mouse ANT isoforms confirms the role of ANT in mPT and provides additional evidence for two independent pores.
Carrer, A. et al. Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase. Nat. Commun. 12, 4835 (2021).
Pinke, G., Zhou, L. & Sazanov, L. A. Cryo-EM structure of the entire mammalian F-type ATP synthase. Nat. Struct. Mol. Biol. 27, 1077–1085 (2020). This study describes for the first time the structure of ATP synthase in conditions of mPTP opening, providing solid confirmation of the c-ring model.
Algieri, C. et al. Mitochondrial Ca2+ -activated F1FO-ATPase hydrolyzes ATP and promotes the permeability transition pore. Ann. NY Acad. Sci. 1457, 142–157 (2019).
Carroll, J., He, J., Ding, S., Fearnley, I. M. & Walker, J. E. Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase. Proc. Natl Acad. Sci. USA 116, 12816–12821 (2019).
He, J. et al. Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase. Proc. Natl Acad. Sci. USA 114, 3409–3414 (2017).
Zhou, W., Marinelli, F., Nief, C. & Faraldo-Gomez, J. D. Atomistic simulations indicate the c-subunit ring of the F1Fo ATP synthase is not the mitochondrial permeability transition pore. eLife 6, e23781 (2017).
Gerle, C. Mitochondrial F-ATP synthase as the permeability transition pore. Pharmacol. Res. 160, 105081 (2020).
Hunter, D. R., Haworth, R. A. & Southard, J. H. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J. Biol. Chem. 251, 5069–5077 (1976).
Kokoszka, J. E. et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427, 461–465 (2004).
Petronilli, V., Nicolli, A., Costantini, P., Colonna, R. & Bernardi, P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta 1187, 255–259 (1994).
Linder, M. D., Morkunaite-Haimi, S., Kinnunen, P. K., Bernardi, P. & Eriksson, O. Ligand-selective modulation of the permeability transition pore by arginine modification. Opposing effects of p-hydroxyphenylglyoxal and phenylglyoxal. J. Biol. Chem. 277, 937–942 (2002).
Zorov, D. B., Kinnally, K. W., Perini, S. & Tedeschi, H. Multiple conductance levels in rat heart inner mitochondrial membranes studied by patch clamping. Biochim. Biophys. Acta 1105, 263–270 (1992).
Halestrap, A. P., Connern, C. P., Griffiths, E. J. & Kerr, P. M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol. Cell Biochem. 174, 167–172 (1997). This work identifies CypD as the target of CsA in mPTP inhibition.
Kanno, T. et al. Oxidative stress underlies the mechanism for Ca2+-induced permeability transition of mitochondria. Free Radic. Res. 38, 27–35 (2004).
Kowaltowski, A. J., Netto, L. E. & Vercesi, A. E. The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. Evidence for the participation of reactive oxygen species in this mechanism. J. Biol. Chem. 273, 12766–12769 (1998).
Costantini, P., Chernyak, B. V., Petronilli, V. & Bernardi, P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271, 6746–6751 (1996).
Halestrap, A. P., Woodfield, K. Y. & Connern, C. P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272, 3346–3354 (1997).
Kaludercic, N. & Giorgio, V. The dual function of reactive oxygen/nitrogen species in bioenergetics and cell death: the role of ATP synthase. Oxid. Med. Cell Longev. 2016, 3869610 (2016).
Vercesi, A. E., Kowaltowski, A. J., Grijalba, M. T., Meinicke, A. R. & Castilho, R. F. The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 17, 43–52 (1997).
Kowaltowski, A. J., Castilho, R. F. & Vercesi, A. E. Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial-generated reactive oxygen species. FEBS Lett. 378, 150–152 (1996).
Kowaltowski, A. J., Vercesi, A. E., Rhee, S. G. & Netto, L. E. Catalases and thioredoxin peroxidase protect Saccharomyces cerevisiae against Ca2+-induced mitochondrial membrane permeabilization and cell death. FEBS Lett. 473, 177–182 (2000).
Samovski, D., Kalderon, B., Yehuda-Shnaidman, E. & Bar-Tana, J. Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs in vivo. J. Biol. Chem. 285, 6879–6890 (2010).
Betaneli, V., Petrov, E. P. & Schwille, P. The role of lipids in VDAC oligomerization. Biophys. J. 102, 523–531 (2012).
Wieckowski, M. R., Brdiczka, D. & Wojtczak, L. Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore. FEBS Lett. 484, 61–64 (2000).
Furuno, T. et al. Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem. Pharmacol. 62, 1037–1046 (2001).
Oyanagi, E., Yano, H., Uchida, M., Utsumi, K. & Sasaki, J. Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acid stress. Biochem. Biophys. Res. Commun. 412, 61–67 (2011).
Kang, B. H. et al. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131, 257–270 (2007).
Ghosh, J. C., Siegelin, M. D., Dohi, T. & Altieri, D. C. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res. 70, 8988–8993 (2010).
Sinha, D. & D’Silva, P. Chaperoning mitochondrial permeability transition: regulation of transition pore complex by a J-protein, DnaJC15. Cell Death Dis. 5, e1101 (2014).
Margineantu, D. H., Emerson, C. B., Diaz, D. & Hockenbery, D. M. Hsp90 inhibition decreases mitochondrial protein turnover. PLoS ONE 2, e1066 (2007).
Hafner, A. V. et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2, 914–923 (2010).
Bochaton, T. et al. Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D. J. Mol. Cell Cardiol. 84, 61–69 (2015).
Yang, W. et al. Mitochondrial sirtuin network reveals dynamic SIRT3-dependent deacetylation in response to membrane depolarization. Cell 167, 985–1000.e21 (2016).
Lee, C. F. et al. Normalization of NAD+ redox balance as a therapy for heart failure. Circulation 134 (2016).
Rasola, A. et al. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc. Natl Acad. Sci. USA 107, 726–731 (2010). This study demonstrates for the first time that signalling pathways can have a direct effect on mPTP activity.
Hurst, S. et al. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion. Cell Death Dis. 11, 661 (2020).
Nishihara, M. et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J. Mol. Cell Cardiol. 43, 564–570 (2007).
Wang, S. et al. Mitochondrial PKC-epsilon deficiency promotes I/R-mediated myocardial injury via GSK3beta-dependent mitochondrial permeability transition pore opening. J. Cell Mol. Med. 21, 2009–2021 (2017).
Tanno, M. et al. Translocation of glycogen synthase kinase-3beta (GSK-3beta), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2). J. Biol. Chem. 289, 29285–29296 (2014).
Gomez, L. et al. The SR/ER-mitochondria calcium crosstalk is regulated by GSK3beta during reperfusion injury. Cell Death Differ. 23, 313–322 (2016).
Yang, K. et al. The key roles of GSK-3beta in regulating mitochondrial activity. Cell Physiol. Biochem. 44, 1445–1459 (2017).
Ghosh, J. C. et al. Adaptive mitochondrial reprogramming and resistance to PI3K therapy. J. Natl Cancer Inst. 107, dju502 (2015).
Whittington, H. J. et al. Over-expression of mitochondrial creatine kinase in the murine heart improves functional recovery and protects against injury following ischaemia-reperfusion. Cardiovasc. Res. 114, 858–869 (2018).
Datler, C. et al. CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex. J. Cell Sci. 127, 1816–1828 (2014).
Woldetsadik, A. D., Vogel, M. C., Rabeh, W. M. & Magzoub, M. Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells. FASEB J. 31, 2168–2184 (2017).
Baines, C. P. et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 92, 873–880 (2003).
Pediaditakis, P. et al. Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes. Biochem. J. 431, 411–421 (2010).
Karch, J. et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. eLife 2, e00772 (2013). This study reveals that OMM remodelling during mPT-induced mitochondrial swelling is dependent on BAX and BAK.
Whelan, R. S. et al. Bax regulates primary necrosis through mitochondrial dynamics. Proc. Natl Acad. Sci. USA 109, 6566–6571 (2012).
Roy, S. S. et al. Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol. Cell 33, 377–388 (2009).
Alavian, K. N. et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 13, 1224–1233 (2011).
Park, H. A. et al. Inhibition of Bcl-xL prevents pro-death actions of DeltaN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity. Cell Death Differ. 24, 1963–1974 (2017).
Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L. & Sollott, S. J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192, 1001–1014 (2000).
Dumas, J. F. et al. Effect of transient and permanent permeability transition pore opening on NAD(P)H localization in intact cells. J. Biol. Chem. 284, 15117–15125 (2009).
Di Lisa, F., Menabo, R., Canton, M., Barile, M. & Bernardi, P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571–2575 (2001).
Jang, S. et al. Elucidating mitochondrial electron transport chain supercomplexes in the heart during ischemia-reperfusion. Antioxid. Redox Signal. 27, 57–69 (2017).
Batandier, C., Leverve, X. & Fontaine, E. Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J. Biol. Chem. 279, 17197–17204 (2004).
McArthur, K. et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359, eaao6047 (2018).
Tavecchio, M., Lisanti, S., Bennett, M. J., Languino, L. R. & Altieri, D. C. Deletion of cyclophilin D impairs beta-oxidation and promotes glucose metabolism. Sci. Rep. 5, 15981 (2015).
Taddeo, E. P. et al. Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle. Mol. Metab. 3, 124–134 (2014).
Laker, R. C. et al. The mitochondrial permeability transition pore regulator cyclophilin D exhibits tissue-specific control of metabolic homeostasis. PLoS ONE 11, e0167910 (2016).
Menazza, S. et al. CypD-/- hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism. J. Mol. Cell Cardiol. 56, 81–90 (2013).
Wang, X. et al. Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis. Hepatology 68, 62–77 (2018).
Zorov, D. B., Juhaszova, M. & Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909–950 (2014).
Bonora, M. et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 34, 1608 (2015).
Bauer, T. M. & Murphy, E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. Circ. Res. 126, 280–293 (2020).
Borutaite, V., Jekabsone, A., Morkuniene, R. & Brown, G. C. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J. Mol. Cell Cardiol. 35, 357–366 (2003).
Precht, T. A. et al. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ. 12, 255–265 (2005).
Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652–658 (2005).
Kim, J. S., He, L. & Lemasters, J. J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304, 463–470 (2003).
Rodriguez-Enriquez, S., Kim, I., Currin, R. T. & Lemasters, J. J. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2, 39–46 (2006). This work describes for the first time that mPTP opening can trigger mitophagy.
Elmore, S. P., Qian, T., Grissom, S. F. & Lemasters, J. J. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 15, 2286–2287 (2001).
Carreira, R. S., Lee, Y., Ghochani, M., Gustafsson, A. B. & Gottlieb, R. A. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy 6, 462–472 (2010).
Rimessi, A. et al. Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction. Autophagy 9, 1677–1686 (2013).
Medina, D. L. & Ballabio, A. Lysosomal calcium regulates autophagy. Autophagy 11, 970–971 (2015).
Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 20, 1013–1022 (2018).
Song, M., Mihara, K., Chen, Y., Scorrano, L. & Dorn, G. W. II Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21, 273–286 (2015).
Vives-Bauza, C. et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA 107, 378–383 (2010).
Baechler, B. L., Bloemberg, D. & Quadrilatero, J. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy 15, 1606–1619 (2019).
Gautier, C. A. et al. Regulation of mitochondrial permeability transition pore by PINK1. Mol. Neurodegener. 7, 22 (2012).
Sun, T. et al. Parkin regulates programmed necrosis and myocardial ischemia/reperfusion injury by targeting cyclophilin-D. Antioxid. Redox Signal. 31, 1177–1193 (2019).
Hom, J. R. et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev. Cell 21, 469–478 (2011). This work provides the first evidence that the mPTP is important for mammalian development, especially in heart formation.
Lingan, J. V., Alanzalon, R. E. & Porter, G. A. Jr. Preventing permeability transition pore opening increases mitochondrial maturation, myocyte differentiation and cardiac function in the neonatal mouse heart. Pediatr. Res. 81, 932–941 (2017).
Gong, G. et al. Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science 350, aad2459 (2015).
Cho, S. W. et al. Dual modulation of the mitochondrial permeability transition pore and redox signaling synergistically promotes cardiomyocyte differentiation from pluripotent stem cells. J. Am. Heart Assoc. 3, e000693 (2014).
Ying, Z. et al. Short-term mitochondrial permeability transition pore opening modulates histone lysine methylation at the early phase of somatic cell reprogramming. Cell Metab. 28, 935–945 e935 (2018).
Tiemeier, G. L. et al. Closing the mitochondrial permeability transition pore in hiPSC-derived endothelial cells induces glycocalyx formation and functional maturation. Stem Cell Rep. 13, 803–816 (2019).
Ito, K., Bonora, M. & Ito, K. Metabolism as master of hematopoietic stem cell fate. Int. J. Hematol. 109, 18–27 (2019).
Folmes, C. D., Ma, H., Mitalipov, S. & Terzic, A. Mitochondria in pluripotent stem cells: stemness regulators and disease targets. Curr. Opin. Genet. Dev. 38, 1–7 (2016).
Garcia-Prat, L. et al. Autophagy maintains stemness by preventing senescence. Nature 529, 37–42 (2016).
Liu, X. et al. Cyclophilin D deficiency protects against the development of mitochondrial ROS and cellular inflammation in aorta. Biochem. Biophys. Res. Commun. 508, 1202–1208 (2019).
Priber, J. et al. Cyclophilin D disruption attenuates lipopolysaccharide-induced inflammatory response in primary mouse macrophages. Biochem. Cell Biol. 93, 241–250 (2015).
Veres, B. et al. Cyclophilin D-dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia. FEBS Open Bio 11, 684–704 (2021).
Dubinin, M. V. et al. Alisporivir improves mitochondrial function in skeletal muscle of mdx mice but suppresses mitochondrial dynamics and biogenesis. Int. J. Mol. Sci. 22, 9780 (2021).
Gao, J. et al. Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. Invest. Ophthalmol. Vis. Sci. 54, 4717–4733 (2013).
Alvarez, V. M., Rama Rao, K. V., Brahmbhatt, M. & Norenberg, M. D. Interaction between cytokines and ammonia in the mitochondrial permeability transition in cultured astrocytes. J. Neurosci. Res. 89, 2028–2040 (2011).
Roca, F. J., Whitworth, L. J., Redmond, S., Jones, A. A. & Ramakrishnan, L. TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell 178, 1344–1361 e1311 (2019).
Garcia, N. & Chavez, E. Mitochondrial DNA fragments released through the permeability transition pore correspond to specific gene size. Life Sci. 81, 1160–1166 (2007).
Patrushev, M. et al. Release of mitochondrial DNA fragments from brain mitochondria of irradiated mice. Mitochondrion 6, 43–47 (2006).
Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222–230 (2011).
Allam, R. et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming. EMBO Rep. 15, 982–990 (2014).
Zamudio, F. et al. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model. J. Neuroinflammation 17, 283 (2020).
Spiller, K. J. et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329–340 (2018).
Leal-Lasarte, M. M., Franco, J. M., Labrador-Garrido, A., Pozo, D. & Roodveldt, C. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia. FASEB J. 31, 2797–2816 (2017).
Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell 183, 636–649.e18 (2020). This study describes the participation of the mPTP in the release of mtDNA as an initiator of inflammation.
Hausenloy, D. J. et al. Mitochondrial ion channels as targets for cardioprotection. J. Cell Mol. Med. 24, 7102–7114 (2020).
Halestrap, A. P. & Richardson, A. P. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. J. Mol. Cell Cardiol. 78, 129–141 (2015).
Ong, S. G. et al. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Cardiovasc. Res. 104, 24–36 (2014).
Cheung, E. C., Ludwig, R. L. & Vousden, K. H. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc. Natl Acad. Sci. USA 109, 20491–20496 (2012).
Liu, R. R. & Murphy, T. H. Reversible cyclosporin A-sensitive mitochondrial depolarization occurs within minutes of stroke onset in mouse somatosensory cortex in vivo: a two-photon imaging study. J. Biol. Chem. 284, 36109–36117 (2009).
Adachi, M., Takahashi, K., Nishikawa, M., Miki, H. & Uyama, M. High intraocular pressure-induced ischemia and reperfusion injury in the optic nerve and retina in rats. Graefes Arch. Clin. Exp. Ophthalmol. 234, 445–451 (1996).
Hwang, J. H. et al. Cyclosporine A attenuates hypoxic-ischemic brain injury in newborn rats. Brain Res. 1359, 208–215 (2010).
Granger, D. N. & Kvietys, P. R. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524–551 (2015).
Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341, 233–249 (1999).
Griffiths, E. J. & Halestrap, A. P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 307, 93–98 (1995). This work provides the first report of the pathological manifestation of the mPTP: cardiac reperfusion injury.
Morciano, G. et al. Mechanistic role of mPTP in ischemia-reperfusion injury. Adv. Exp. Med. Biol. 982, 169–189 (2017).
Upadhaya, S. et al. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: a meta-analysis. Cardiol. J. 24, 43–50 (2017).
Pottecher, J. et al. Skeletal muscle ischemia-reperfusion injury and cyclosporine A in the aging rat. Fundam. Clin. Pharmacol. 30, 216–225 (2016).
Uchino, H. et al. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol. Dis. 10, 219–233 (2002).
Konukoglu, D., Tasci, I. & Cetinkale, O. Effects of cyclosporin A and ibuprofen on liver ischemia-reperfusion injury in the rat. Clin. Chim. Acta 275, 1–8 (1998).
Li, J., Yan, Z. & Fang, Q. A mechanism study underlying the protective effects of cyclosporine-a on lung ischemia-reperfusion injury. Pharmacology 100, 83–90 (2017).
Yazdani, I., Majdani, R., Ghasemnejad-Berenji, M. & Dehpour, A. R. Comparison of multiple doses of cyclosporine A on germ cell apoptosis and epididymal sperm parameters after testicular ischemia/reperfusion in rats. Exp. Mol. Pathol. 110, 104271 (2019).
Ruiz-Meana, M. et al. The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia. Basic. Res. Cardiol. 106, 1259–1268 (2011).
Imahashi, K. et al. Cardiac-specific ablation of the Na+-Ca2+ exchanger confers protection against ischemia/reperfusion injury. Circ. Res. 97, 916–921 (2005).
Imahashi, K., Schneider, M. D., Steenbergen, C. & Murphy, E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95, 734–741 (2004).
Luongo, T. S. et al. The mitochondrial Na+/Ca2+ exchanger is essential for Ca2+homeostasis and viability. Nature 545, 93–97 (2017).
Zhao, Q. et al. The role of the mitochondrial calcium uniporter in cerebral ischemia/reperfusion injury in rats involves regulation of mitochondrial energy metabolism. Mol. Med. Rep. 7, 1073–1080 (2013).
Luongo, T. S. et al. The mitochondrial calcium uniporter matches energetic supply with cardiac workload during stress and modulates permeability transition. Cell Rep. 12, 23–34 (2015).
Mammucari, C., Raffaello, A., Vecellio Reane, D. & Rizzuto, R. Molecular structure and pathophysiological roles of the mitochondrial calcium uniporter. Biochim. Biophys. Acta 1863, 2457–2464 (2016).
Morciano, G. et al. A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients. Cell Rep. 35, 108983 (2021). This study identifies for the first time a mutation in a molecular component of the mPTP associated with negative outcome of heart infarction.
Cardenas, M. E., Zhu, D. & Heitman, J. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr. Opin. Nephrol. Hypertens. 4, 472–477 (1995).
El Baradie, K. B. Y. et al. The cyclophilin inhibitor NIM-811 increases muscle cell survival with hypoxia in vitro and improves gait performance following ischemia-reperfusion in vivo. Sci. Rep. 11, 6152 (2021).
Gomez, L. et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 293, H1654–H1661 (2007).
Panel, M. et al. Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia/reperfusion injury. Gastroenterology 157, 1368–1382 (2019).
Fancelli, D. et al. Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo. J. Med. Chem. 57, 5333–5347 (2014).
Antonucci, S. et al. A novel class of cardioprotective small-molecule PTP inhibitors. Pharmacol. Res. 151, 104548 (2020).
Morciano, G. et al. Discovery of novel 1,3,8-triazaspiro[4.5]decane derivatives that target the c subunit of F1/FO-adenosine triphosphate (ATP) synthase for the treatment of reperfusion damage in myocardial infarction. J. Med. Chem. 61, 7131–7143 (2018).
Botker, H. E., Cabrera-Fuentes, H. A., Ruiz-Meana, M., Heusch, G. & Ovize, M. Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction. J. Cell Mol. Med. 24, 2717–2729 (2020).
Linkermann, A., De Zen, F., Weinberg, J., Kunzendorf, U. & Krautwald, S. Programmed necrosis in acute kidney injury. Nephrol. Dial. Transpl. 27, 3412–3419 (2012).
Mulay, S. R. et al. Mitochondria permeability transition versus necroptosis in oxalate-induced AKI. JASN 30, 1857–1869 (2019).
Ishimoto, Y. & Inagi, R. Mitochondria: a therapeutic target in acute kidney injury. Nephrol. Dial. Transpl. 31, 1062–1069 (2016).
Bao, H. et al. Inhibition of glycogen synthase kinase-3beta prevents NSAID-induced acute kidney injury. Kidney Int. 81, 662–673 (2012).
Wang, Z. et al. Redox-sensitive glycogen synthase kinase 3beta-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury. Free Radic. Biol. Med. 65, 849–858 (2013).
Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 110, 12024–12029 (2013).
Beck, S. J. et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease. Nat. Commun. 7, 11483 (2016).
Du, H. et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat. Med. 14, 1097–1105 (2008).
Gomez-Lazaro, M. et al. 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J. Neurochem. 104, 1599–1612 (2008).
Martin, L. J., Semenkow, S., Hanaford, A. & Wong, M. Mitochondrial permeability transition pore regulates Parkinson’s disease development in mutant alpha-synuclein transgenic mice. Neurobiol. Aging 35, 1132–1152 (2014).
Sun, A. et al. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. J. Am. Heart Assoc. 3, e000779 (2014).
Manczak, M. & Reddy, P. H. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer’s disease. Hum. Mol. Genet. 21, 5131–5146 (2012).
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G. & Anandatheerthavarada, H. K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089–9100 (2008).
Yao, J. et al. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer’s disease. J. Neurosci. 31, 2313–2320 (2011).
Liu, G. et al. α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci. Lett. 454, 187–192 (2009).
Zhu, Y. et al. α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. Int. J. Biochem. Cell Biol. 43, 732–741 (2011).
Sileikyte, J. & Forte, M. The mitochondrial permeability transition in mitochondrial disorders. Oxid. Med. Cell Longev. 2019, 3403075 (2019).
Dagda, R. K., Das Banerjee, T. & Janda, E. How Parkinsonian toxins dysregulate the autophagy machinery. Int. J. Mol. Sci. 14, 22163–22189 (2013).
Rasheed, M. Z., Tabassum, H. & Parvez, S. Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease. Protoplasma 254, 33–42 (2017).
Tillement, L., Lecanu, L., Yao, W., Greeson, J. & Papadopoulos, V. The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function. Steroids 71, 725–735 (2006).
Xie, H. et al. Mitochondrial alterations near amyloid plaques in an Alzheimer’s disease mouse model. J. Neurosci. 33, 17042–17051 (2013).
Atlante, A. et al. A peptide containing residues 26–44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. Biochim. Biophys. Acta 1777, 1289–1300 (2008).
Ludtmann, M. H. R. et al. alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease. Nat. Commun. 9, 2293 (2018).
Du, F. et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease. Brain 140, 3233–3251 (2017).
Fang, E. F. et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat. Neurosci. 22, 401–412 (2019).
Haroon, M. F. et al. Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11,778 mutation. Neurobiol. Dis. 28, 237–250 (2007).
Cotan, D. et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J. 25, 2669–2687 (2011).
Wong, A. & Cortopassi, G. mtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem. Biophys. Res. Commun. 239, 139–145 (1997).
Burelle, Y. et al. Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French Canadian patients. PLoS ONE 10, e0120767 (2015).
Martin, L. J. et al. GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis. Front. Cell Neurosci. 8, 433 (2014).
Valasani, K. R. et al. Identification of a small molecule cyclophilin D inhibitor for rescuing Aβ-mediated mitochondrial dysfunction. ACS Med. Chem. Lett. 7, 294–299 (2016).
Parone, P. A. et al. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 33, 4657–4671 (2013).
Rottenberg, H. & Wu, S. Mitochondrial dysfunction in lymphocytes from old mice: enhanced activation of the permeability transition. Biochem. Biophys. Res. Commun. 240, 68–74 (1997).
Goodell, S. & Cortopassi, G. Analysis of oxygen consumption and mitochondrial permeability with age in mice. Mech. Ageing Dev. 101, 245–256 (1998).
Mather, M. & Rottenberg, H. Aging enhances the activation of the permeability transition pore in mitochondria. Biochem. Biophys. Res. Commun. 273, 603–608 (2000).
Shen, E. Z. et al. Mitoflash frequency in early adulthood predicts lifespan in Caenorhabditis elegans. Nature 508, 128–132 (2014).
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630–655 (2019).
Schriewer, J. M., Peek, C. B., Bass, J. & Schumacker, P. T. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J. Am. Heart Assoc. 2, e000159 (2013).
Gauba, E., Guo, L. & Du, H. Cyclophilin D promotes brain mitochondrial F1FO ATP synthase dysfunction in aging mice. J. Alzheimers Dis. 55, 1351–1362 (2017).
Vereczki, V. et al. Cyclophilin D regulates lifespan and protein expression of aging markers in the brain of mice. Mitochondrion 34, 115–126 (2017).
Diot, A., Morten, K. & Poulton, J. Mitophagy plays a central role in mitochondrial ageing. Mamm. Genome 27, 381–395 (2016).
Markaki, M., Palikaras, K. & Tavernarakis, N. Novel insights into the anti-aging role of mitophagy. Int. Rev. Cell Mol. Biol. 340, 169–208 (2018).
Sun, N., Youle, R. J. & Finkel, T. The mitochondrial basis of aging. Mol. Cell 61, 654–666 (2016).
Madeo, F., Zimmermann, A., Maiuri, M. C. & Kroemer, G. Essential role for autophagy in life span extension. J. Clin. Invest. 125, 85–93 (2015).
Hansen, M., Rubinsztein, D. C. & Walker, D. W. Autophagy as a promoter of longevity: insights from model organisms. Nat. Rev. Mol. Cell Biol. 19, 579–593 (2018).
Fernandez, A. F. et al. Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558, 136–140 (2018).
Aspernig, H. et al. Mitochondrial perturbations couple mTORC2 to autophagy in C.elegans. Cell Rep. 29, 1399–1409.e5 (2019).
Zhou, B. et al. Mitochondrial permeability uncouples elevated autophagy and lifespan extension. Cell 177, 299–314.e16 (2019). This study provides evidence that the mPTP can determine the impact of autophagy on lifespan.
Aggarwal, V. et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules 9, 735 (2019).
Giorgi, C. et al. Mitochondria and reactive oxygen species in aging and age-related diseases. Int. Rev. Cell Mol. Biol. 340, 209–344 (2018).
Marchi, S. et al. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth. EMBO J. 38, e99435 (2019).
Bittremieux, M., Parys, J. B., Pinton, P. & Bultynck, G. ER functions of oncogenes and tumor suppressors: modulators of intracellular Ca2+ signaling. Biochim. Biophys. Acta 1863, 1364–1378 (2016).
Rimessi, A., Marchi, S., Patergnani, S. & Pinton, P. H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene 33, 2329–2340 (2014).
Bononi, A. et al. Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ. 20, 1631–1643 (2013).
Giorgi, C. et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc. Natl Acad. Sci. USA 112, 1779–1784 (2015).
Giorgi, C. et al. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget 6, 1435–1445 (2015).
Bononi, A. et al. BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation. Nature 546, 549–553 (2017).
Giorgi, C. et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330, 1247–1251 (2010). This work, together with Marchi et al. (2019), Bittremieux et al. (2016), Rimessi et al. (2014), Bononi et al. (2013), both Giorgi et al. (2015) and Bononi et al. (2017), demonstrate roles for oncogenes and oncosuppressor genes in the regulation of mitochondrial Ca2+ and the regulation of cell death.
Vaseva, A. V. et al. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536–1548 (2012).
Bergeaud, M. et al. Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F1F0-ATP synthase. Cell Cycle 12, 2781–2793 (2013).
Lebedev, I. et al. A novel in vitro CypD-mediated p53 aggregation assay suggests a model for mitochondrial permeability transition by chaperone systems. J. Mol. Biol. 428, 4154–4167 (2016).
Hagn, F. et al. Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53. Nat. Struct. Mol. Biol. 18, 1086–1093 (2011).
Giorgio, V., Fogolari, F., Lippe, G. & Bernardi, P. OSCP subunit of mitochondrial ATP synthase: role in regulation of enzyme function and of its transition to a pore. Br. J. Pharmacol. 176, 4247–4257 (2019).
Dolder, M., Walzel, B., Speer, O., Schlattner, U. & Wallimann, T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278, 17760–17766 (2003).
Chappell, J. B. & Crofts, A. R. Calcium ion accumulation and volume changes of isolated liver mitochondria. calcium ion-induced swelling. Biochem. J. 95, 378–386 (1965).
Azzi, A. & Azzone, G. F. Swelling and shrinkage phenomena in liver mitochondria. III. Irreversible swelling induced by inorganic phosphate and Ca2+. Biochim. Biophys. Acta 113, 438–444 (1966).
Sambri, I. et al. Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia. EBioMedicine 61, 103050 (2020).
Shore, E. R. et al. Small molecule inhibitors of cyclophilin D to protect mitochondrial function as a potential treatment for acute pancreatitis. J. Med. Chem. 59, 2596–2611 (2016).
Irwin, W. A. et al. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet. 35, 367–371 (2003).
Davis, T. L. et al. Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol. 8, e1000439 (2010).
Masubuchi, Y., Suda, C. & Horie, T. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J. Hepatol. 42, 110–116 (2005).
Hansson, M. J. et al. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J. Bioenerg. Biomembr. 36, 407–413 (2004).
Chen, V. M. et al. Collagen VII deficient mice show morphologic and histologic corneal changes that phenotypically mimic human dystrophic epidermolysis bullosa of the eye. Exp. Eye Res. 175, 133–141 (2018).
Tiepolo, T. et al. The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1−/− myopathic mice. Br. J. Pharmacol. 157, 1045–1052 (2009).
Reutenauer, J., Dorchies, O. M., Patthey-Vuadens, O., Vuagniaux, G. & Ruegg, U. T. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br. J. Pharmacol. 155, 574–584 (2008).
Alavian, K. N. et al. The mitochondrial complex V-associated large-conductance inner membrane current is regulated by cyclosporine and dexpramipexole. Mol. Pharmacol. 87, 1–8 (2015).
Kang, B. H. et al. Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin. Cancer Res. 16, 4779–4788 (2010).
Richardson, A. P. & Halestrap, A. P. Quantification of active mitochondrial permeability transition pores using GNX-4975 inhibitor titrations provides insights into molecular identity. Biochem. J. 473, 1129–1140 (2016).
Warne, J. et al. Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis. J. Biol. Chem. 291, 4356–4373 (2016).
Sileikyte, J. etal. in Probe Reports from the NIH Molecular Libraries Program (National Center for Biotechnology Information, 2010).
Waldmeier, P. C., Feldtrauer, J. J., Qian, T. & Lemasters, J. J. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62, 22–29 (2002).
Shares, B. H. et al. Inhibition of the mitochondrial permeability transition improves bone fracture repair. Bone 137, 115391 (2020).
Garbaisz, D. et al. Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811. PLoS ONE 9, e101067 (2014).
Korde, A. S. et al. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J. Neurotrauma 24, 895–908 (2007).
Clarke, S. J., McStay, G. P. & Halestrap, A. P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 277, 34793–34799 (2002).
Tanaka, T. et al. Glycogen synthase kinase-3beta opens mitochondrial permeability transition pore through mitochondrial hexokinase II dissociation. J. Physiol. Sci. 68, 865–871 (2018).
Shteinfer-Kuzmine, A., Amsalem, Z., Arif, T., Zooravlov, A. & Shoshan-Barmatz, V. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy. Mol. Oncol. 12, 1077–1103 (2018).
Miyamoto, S., Murphy, A. N. & Brown, J. H. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 15, 521–529 (2008).
Sun, J. et al. Desensitizing mitochondrial permeability transition by ERK-cyclophilin D axis contributes to the neuroprotective effect of gallic acid against cerebral ischemia/reperfusion injury. Front. Pharmacol. 8, 184 (2017).
Wu, R. et al. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol. Med. 4, 633–646 (2012).
Pravdic, D. et al. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein kinase C-epsilon-mediated pathway. Anesthesiology 111, 267–274 (2009).
Shanmughapriya, S. et al. SPG7 Is an essential and conserved component of the mitochondrial permeability transition pore. Mol. Cell 60, 47–62 (2015).
Hurst, S., Baggett, A., Csordas, G. & Sheu, S. S. SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, Ca2+ influx, and regulation of mitochondrial permeability transition pore opening. J. Biol. Chem. 294, 10807–10818 (2019).
Valasani, K. R., Vangavaragu, J. R., Day, V. W. & Yan, S. S. Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors. J. Chem. Inf. Model. 54, 902–912 (2014).
Ni, S. et al. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach. J. Med. Chem. 52, 5295–5298 (2009).
Guichou, J. F. et al. Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J. Med. Chem. 49, 900–910 (2006).
Schinzel, A. C. et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl Acad. Sci. USA 102, 12005–12010 (2005).
Ades, L., Itzykson, R. & Fenaux, P. Myelodysplastic syndromes. Lancet 383, 2239–2252 (2014).
Yu, W. et al. Cyclosporine a suppressed glucose oxidase induced p53 mitochondrial translocation and hepatic cell apoptosis through blocking mitochondrial permeability transition. Int. J. Biol. Sci. 12, 198–209 (2016).
Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J. & Molkentin, J. D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9, 550–555 (2007).
McEnery, M. W., Snowman, A. M., Trifiletti, R. R. & Snyder, S. H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl Acad. Sci. USA 89, 3170–3174 (1992).
Marzo, I. et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027–2031 (1998).
Cheng, E. H., Sheiko, T. V., Fisher, J. K., Craigen, W. J. & Korsmeyer, S. J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301, 513–517 (2003).
Kinnally, K. W. et al. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl Acad. Sci. USA 90, 1374–1378 (1993).
Beutner, G., Ruck, A., Riede, B. & Brdiczka, D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim. Biophys. Acta 1368, 7–18 (1998).
Ruck, A., Dolder, M., Wallimann, T. & Brdiczka, D. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Lett. 426, 97–101 (1998).
Sileikyte, J. et al. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18kDa (TSPO)). J. Biol. Chem. 289, 13769–13781 (2014).
Herick, K., Kramer, R. & Luhring, H. Patch clamp investigation into the phosphate carrier from Saccharomyces cerevisiae mitochondria. Biochim. Biophys. Acta 1321, 207–220 (1997).
Leung, A. W., Varanyuwatana, P. & Halestrap, A. P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J. Biol. Chem. 283, 26312–26323 (2008).
Gutierrez-Aguilar, M. et al. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition. J. Mol. Cell Cardiol. 72, 316–325 (2014).
Klutho, P. J., Dashek, R. J., Song, L. & Baines, C. P. Genetic manipulation of SPG7 or NipSnap2 does not affect mitochondrial permeability transition. Cell Death Discov. 6, 5 (2020).
Porter, G. A. Jr. & Beutner, G. Cyclophilin D, somehow a master regulator of mitochondrial function. Biomolecules 8, 176 (2018).
Acknowledgements
The Signal Transduction Laboratory is supported by the Italian Association for Cancer Research (IG-23670 to P.P. and IG-19803 to C.G.), A-ROSE, Progetti di Rilevante Interesse Nazionale (PRIN2017E5L5P3 to P.P and PRIN20177E9EPY to C.G.), the Italian Ministry of Health (GR-2013-02356747 to C.G.), the European Research Council (853057-InflaPML to C.G.) and local funds from the University of Ferrara to M.B., C.G. and P.P. P.P. is grateful to C. degli Scrovegni for her continuous support.
Author information
Authors and Affiliations
Contributions
All authors researched data for the article, contributed to discussion of the content, wrote the article and edited the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Molecular Cell Biology thanks Valentina Giorgio and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Glossary
- Voltage-dependent anion channel
-
(VDAC). A pore-forming protein of the outer mitochondrial membrane which allows the exchange of metabolites and ions.
- Cyclosporine A
-
(CsA). A cyclic polypeptide able to bind and inhibit cyclophilins, including the mitochondrial permeability transition pore regulator cyclophilin D (CypD).
- Adenine nucleotide translocator
-
(ANT). An integral membrane protein that exchanges ATP for ADP across the inner mitochondrial membrane.
- Mitochondrial inorganic phosphate carrier
-
(PiC). An integral carrier solute that delivers phosphate across the inner mitochondrial membrane.
- c-ring
-
A portion of the ATP synthase rotor (composed of an octamer of subunit c) responsible for the coupling of proton transport across the inner mitochondrial membrane to a rotative movement required for catalysis.
- Cristae
-
Foldings of the inner membrane that create specialized compartments required to optimize mitochondrial functions.
- Cyclophilin D
-
(CypD). A peptidyl-prolyl cis–trans isomerase located in the mitochondrial matrix. By binding to mitochondrial ATP synthase, it functions as a positive regulator of mitochondrial permeability transition pore (mPTP) opening and the target of the mPTP inhibitor cyclosporine A (CsA).
- Mitoplasts
-
Mitochondria artificially deprived of the outer mitochondrial membrane.
- Mitochondrial membrane potential
-
The electric potential generated across inner mitochondrial membrane by the proton pumping activity of respiratory complexes.
- BCL-2 family
-
A group of evolutionarily conserved proteins that harbour a BCL-2 homology domain. Mostly known for their regulatory role in regulated cell death, mostly apoptosis.
- Sirtuin
-
Member of a family of NAD-dependent protein deacetylases or (ADP-ribosyl)transferases able to respond to nutrient stress, potentiating mitochondrial biogenesis and activity.
- ERK-mediated signalling
-
A signal transduction pathway regulating cellular processes that includes proliferation, differentiation, apoptosis and stress responses, having a major impact in tumour development.
- Respiratory chain
-
A group of multimeric protein complexes in the inner mitochondrial membrane, carrying mitochondrial respiration.
- Necrosis
-
A form of poorly regulated cell death characterized by energetic crisis and its consequent chaotic disruption of intracellular structures.
- Mitophagy
-
The selective degradation of a mitochondrion via the lysosomal machinery.
- PINK1–parkin system
-
A kinase/ubiquitinase system required for the tagging of outer mitochondrial membrane proteins, which in turn label mitochondria to be cleared via lysosomal degradation.
- Damage-associated molecular pattern
-
A molecule released from a damaged or diseased cell able to stimulate a sterile immune or inflammatory response.
- Inflammasome
-
A group of intracellular multimeric protein complexes that activate inflammatory caspase 1.
- Amyotrophic lateral sclerosis
-
A progressive neurological disease that primarily affects the neurons responsible for controlling voluntary muscle movement.
- Ischaemia
-
The deficient supply of blood to a tissue due to obstruction of the inflow of arterial blood.
- Reperfusion injury
-
Type of tissue damage that is caused by the restoration of blood supply after a prolonged period of ischaemia.
- Necroptosis
-
A form of regulated cell death initiated by death receptors and dependent on RIPK1, RIPK3 and MLKL.
- Ullrich congenital muscular dystrophy
-
A rare hereditary muscle condition characterized by abnormalities in collagen type VI, resulting in impaired progressive muscle weakness.
- Free radical theory of ageing
-
A theory of ageing proposing that organisms age because they accumulate oxidative damage.
- NAD+
-
A molecule that carries reduced equivalents between enzymes to run redox reactions. Decline in its level is associated with ageing and ageing-related mitochondrial dysfunction.
Rights and permissions
About this article
Cite this article
Bonora, M., Giorgi, C. & Pinton, P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol 23, 266–285 (2022). https://doi.org/10.1038/s41580-021-00433-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41580-021-00433-y
This article is cited by
-
Mitochondrial mechanisms in the pathogenesis of chronic inflammatory musculoskeletal disorders
Cell & Bioscience (2024)
-
Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer
Cancer Cell International (2024)
-
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Critical Care (2024)
-
Calcium signaling from sarcoplasmic reticulum and mitochondria contact sites in acute myocardial infarction
Journal of Translational Medicine (2024)
-
Targeting mitochondrial quality control: new therapeutic strategies for major diseases
Military Medical Research (2024)